Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients

Background/aimsTo validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma.MethodsWe performed a retrospective review of 100 consecutive patients with eyelid seb...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of ophthalmology Vol. 103; no. 7; pp. 980 - 984
Main Authors:	Sa, Ho-Seok, Rubin, Maria Laura, Xu, Shiqiong, Ning, Jing, Tetzlaff, Michael, Sagiv, Oded, Kandl, Thomas J, Esmaeli, Bita
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group LTD 01.07.2019
Subjects:	Adult Aged Aged, 80 and over Biopsy Cancer therapies Chemotherapy Classification Committees Ethnicity Eye cancer Eyelid Neoplasms - diagnosis Eyelid Neoplasms - mortality Eyelid Neoplasms - secondary Eyelids - pathology Family medical history Female Follow-Up Studies Head & neck cancer Humans Incidence Lymphatic Metastasis Lymphatic system Male Medical prognosis Metastasis Middle Aged Neoplasm Recurrence, Local - epidemiology Neoplasm Staging Ophthalmology Patients Plastic surgery Prognosis Retrospective Studies Sebaceous Gland Neoplasms - diagnosis Sebaceous Gland Neoplasms - mortality Sebaceous Gland Neoplasms - secondary Survival Rate - trends Tumors United States - epidemiology United States United States > US eyelid carcinoma metastasis 8th TNM AJCC survival staging system sebaceous carcinoma
ISSN:	0007-1161, 1468-2079, 1468-2079
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Background/aimsTo validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma.MethodsWe performed a retrospective review of 100 consecutive patients with eyelid sebaceous carcinoma. Eyelid carcinomas were staged according to the AJCC 7th-edition and 8th-edition criteria. Associations between T and N categories and disease-related outcomes including local recurrence, lymph node metastasis, distant metastasis and survival were evaluated.Results60 women and 40 men had a median age of 67 years (range, 41–94 years). The proportions of patients who experienced local recurrence, lymph node metastasis, distant metastasis and death from disease were 6%, 21%, 7% and 6%, respectively. Two-year and 5-year disease-specific survival (DSS) rates were 93.8% and 92.0%, respectively. There were significant correlations between (1) T2c or worse category and lymph node metastasis (p=0.04) and distant metastasis (p=0.01), (2) T3b or worse category and local recurrence (p=0.01) and death from disease (p=0.01) and (3) N1 category at presentation and distant metastasis (p<0.01) and death from disease (p<0.01). The AJCC 8th-edition classification showed a better homogeneity of the T-category distribution (p<0.01) and a slightly higher discrimination ability for lymph node metastasis (C=0.734 vs C=0.728) than the 7th-edition.ConclusionsT and N categories per AJCC 8th-edition classification are predictive of local recurrence, metastasis and DSS outcomes for eyelid sebaceous carcinoma. Surgeons should perform strict surveillance testing for nodal and systemic metastases in patients with T2c or worse T category and/or N1 disease at presentation.
AbstractList	Background/aimsTo validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma.MethodsWe performed a retrospective review of 100 consecutive patients with eyelid sebaceous carcinoma. Eyelid carcinomas were staged according to the AJCC 7th-edition and 8th-edition criteria. Associations between T and N categories and disease-related outcomes including local recurrence, lymph node metastasis, distant metastasis and survival were evaluated.Results60 women and 40 men had a median age of 67 years (range, 41–94 years). The proportions of patients who experienced local recurrence, lymph node metastasis, distant metastasis and death from disease were 6%, 21%, 7% and 6%, respectively. Two-year and 5-year disease-specific survival (DSS) rates were 93.8% and 92.0%, respectively. There were significant correlations between (1) T2c or worse category and lymph node metastasis (p=0.04) and distant metastasis (p=0.01), (2) T3b or worse category and local recurrence (p=0.01) and death from disease (p=0.01) and (3) N1 category at presentation and distant metastasis (p<0.01) and death from disease (p<0.01). The AJCC 8th-edition classification showed a better homogeneity of the T-category distribution (p<0.01) and a slightly higher discrimination ability for lymph node metastasis (C=0.734 vs C=0.728) than the 7th-edition.ConclusionsT and N categories per AJCC 8th-edition classification are predictive of local recurrence, metastasis and DSS outcomes for eyelid sebaceous carcinoma. Surgeons should perform strict surveillance testing for nodal and systemic metastases in patients with T2c or worse T category and/or N1 disease at presentation. To validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma.BACKGROUND/AIMSTo validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma.We performed a retrospective review of 100 consecutive patients with eyelid sebaceous carcinoma. Eyelid carcinomas were staged according to the AJCC 7th-edition and 8th-edition criteria. Associations between T and N categories and disease-related outcomes including local recurrence, lymph node metastasis, distant metastasis and survival were evaluated.METHODSWe performed a retrospective review of 100 consecutive patients with eyelid sebaceous carcinoma. Eyelid carcinomas were staged according to the AJCC 7th-edition and 8th-edition criteria. Associations between T and N categories and disease-related outcomes including local recurrence, lymph node metastasis, distant metastasis and survival were evaluated.60 women and 40 men had a median age of 67 years (range, 41-94 years). The proportions of patients who experienced local recurrence, lymph node metastasis, distant metastasis and death from disease were 6%, 21%, 7% and 6%, respectively. Two-year and 5-year disease-specific survival (DSS) rates were 93.8% and 92.0%, respectively. There were significant correlations between (1) T2c or worse category and lymph node metastasis (p=0.04) and distant metastasis (p=0.01), (2) T3b or worse category and local recurrence (p=0.01) and death from disease (p=0.01) and (3) N1 category at presentation and distant metastasis (p<0.01) and death from disease (p<0.01). The AJCC 8th-edition classification showed a better homogeneity of the T-category distribution (p<0.01) and a slightly higher discrimination ability for lymph node metastasis (C=0.734 vs C=0.728) than the 7th-edition.RESULTS60 women and 40 men had a median age of 67 years (range, 41-94 years). The proportions of patients who experienced local recurrence, lymph node metastasis, distant metastasis and death from disease were 6%, 21%, 7% and 6%, respectively. Two-year and 5-year disease-specific survival (DSS) rates were 93.8% and 92.0%, respectively. There were significant correlations between (1) T2c or worse category and lymph node metastasis (p=0.04) and distant metastasis (p=0.01), (2) T3b or worse category and local recurrence (p=0.01) and death from disease (p=0.01) and (3) N1 category at presentation and distant metastasis (p<0.01) and death from disease (p<0.01). The AJCC 8th-edition classification showed a better homogeneity of the T-category distribution (p<0.01) and a slightly higher discrimination ability for lymph node metastasis (C=0.734 vs C=0.728) than the 7th-edition.T and N categories per AJCC 8th-edition classification are predictive of local recurrence, metastasis and DSS outcomes for eyelid sebaceous carcinoma. Surgeons should perform strict surveillance testing for nodal and systemic metastases in patients with T2c or worse T category and/or N1 disease at presentation.CONCLUSIONST and N categories per AJCC 8th-edition classification are predictive of local recurrence, metastasis and DSS outcomes for eyelid sebaceous carcinoma. Surgeons should perform strict surveillance testing for nodal and systemic metastases in patients with T2c or worse T category and/or N1 disease at presentation. To validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma. We performed a retrospective review of 100 consecutive patients with eyelid sebaceous carcinoma. Eyelid carcinomas were staged according to the AJCC 7th-edition and 8th-edition criteria. Associations between T and N categories and disease-related outcomes including local recurrence, lymph node metastasis, distant metastasis and survival were evaluated. 60 women and 40 men had a median age of 67 years (range, 41-94 years). The proportions of patients who experienced local recurrence, lymph node metastasis, distant metastasis and death from disease were 6%, 21%, 7% and 6%, respectively. Two-year and 5-year disease-specific survival (DSS) rates were 93.8% and 92.0%, respectively. There were significant correlations between (1) T2c or worse category and lymph node metastasis (p=0.04) and distant metastasis (p=0.01), (2) T3b or worse category and local recurrence (p=0.01) and death from disease (p=0.01) and (3) N1 category at presentation and distant metastasis (p<0.01) and death from disease (p<0.01). The AJCC 8th-edition classification showed a better homogeneity of the T-category distribution (p<0.01) and a slightly higher discrimination ability for lymph node metastasis (C=0.734 vs C=0.728) than the 7th-edition. T and N categories per AJCC 8th-edition classification are predictive of local recurrence, metastasis and DSS outcomes for eyelid sebaceous carcinoma. Surgeons should perform strict surveillance testing for nodal and systemic metastases in patients with T2c or worse T category and/or N1 disease at presentation.
Author	Ning, Jing Rubin, Maria Laura Sagiv, Oded Xu, Shiqiong Sa, Ho-Seok Kandl, Thomas J Tetzlaff, Michael Esmaeli, Bita
Author_xml	– sequence: 1 givenname: Ho-Seok surname: Sa fullname: Sa, Ho-Seok email: besmaeli@mdanderson.org organization: Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea – sequence: 2 givenname: Maria Laura surname: Rubin fullname: Rubin, Maria Laura email: besmaeli@mdanderson.org organization: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA – sequence: 3 givenname: Shiqiong surname: Xu fullname: Xu, Shiqiong email: besmaeli@mdanderson.org organization: Department of Ophthalmology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China – sequence: 4 givenname: Jing surname: Ning fullname: Ning, Jing email: besmaeli@mdanderson.org organization: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA – sequence: 5 givenname: Michael surname: Tetzlaff fullname: Tetzlaff, Michael email: besmaeli@mdanderson.org organization: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA – sequence: 6 givenname: Oded surname: Sagiv fullname: Sagiv, Oded email: besmaeli@mdanderson.org organization: Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA – sequence: 7 givenname: Thomas J surname: Kandl fullname: Kandl, Thomas J email: besmaeli@mdanderson.org organization: Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA – sequence: 8 givenname: Bita surname: Esmaeli fullname: Esmaeli, Bita email: besmaeli@mdanderson.org organization: Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30131380$$D View this record in MEDLINE/PubMed
BookMark	eNqNkcuKFDEUhoOMOD2jryABNy4szaUqlXIhDIM3GNCFrouT1Imdpippk1TD7H1w0_YoMqsJgXDCd_5z-S_IWYgBCaGcveZcqjdmF_fbsoV5iXMjGNeN5ELJ7hHZ8Fbp-tUPZ2TDGOsbzhU_Jxc572ooFO-fkHPJuORSsw359TXFHyHm4i11YEtMmbqY6BwtzDShXVPCYPEVXbBArtdnCmGieU0Hf6jMkc5owGJcM7WQrA9xARodLVukeIuzn97SaDKmAxQfQ6Y-1FEY3dcQQ8lPyWMHc8Znd-8l-f7h_bfrT83Nl4-fr69uGtMxWRqnjRiYBGPrGMpgK0zHJTN9PUIpB4NjoNUg3QS661voLMiJTVbwXiM4eUlennT3Kf5cMZdx8dniPEM4Nj8KNnDNlea6oi_uobu4plC7G4Vo264bpGgr9fyOWs2C07hPfoF0O_7dbwX0CbAp5pzQ_UM4G49Wjv9bOR6tHE9W1tR391KtL3_2VxL4-SEC8iRglt3Dy_4G7Pm8iw
CitedBy_id	crossref_primary_10_1007_s00238_023_02137_2 crossref_primary_10_1016_j_ajo_2024_07_036 crossref_primary_10_4274_BMB_galenos_2024_2023_10_096 crossref_primary_10_3390_ijms251810183 crossref_primary_10_1038_s41598_024_80732_4 crossref_primary_10_1007_s10384_020_00756_x crossref_primary_10_1136_bmjopen_2024_086213 crossref_primary_10_1007_s00403_022_02481_6 crossref_primary_10_1038_s41433_019_0756_9 crossref_primary_10_1097_DSS_0000000000004016 crossref_primary_10_1007_s12105_021_01353_1 crossref_primary_10_1097_DAD_0000000000001812 crossref_primary_10_1038_s41379_020_0454_y crossref_primary_10_1111_aos_15204 crossref_primary_10_1186_s12885_025_13833_6 crossref_primary_10_3390_ijms22168454 crossref_primary_10_1136_jclinpath_2019_206147 crossref_primary_10_1007_s00403_023_02747_7 crossref_primary_10_1016_j_jaad_2022_07_015 crossref_primary_10_1136_bjo_2024_326923 crossref_primary_10_3389_fonc_2023_981111 crossref_primary_10_4103_ijo_IJO_155_21 crossref_primary_10_1111_his_14044 crossref_primary_10_1167_iovs_66_1_40 crossref_primary_10_1002_jso_26774 crossref_primary_10_1136_bjophthalmol_2021_320547 crossref_primary_10_3341_kjo_2024_0003 crossref_primary_10_1007_s00403_019_01971_4 crossref_primary_10_1111_ddg_15405_g crossref_primary_10_1111_aos_14552 crossref_primary_10_1177_1120672120936488 crossref_primary_10_3892_ol_2025_15263 crossref_primary_10_1111_cup_13987 crossref_primary_10_1158_1078_0432_CCR_20_2473 crossref_primary_10_1007_s00105_021_04829_x crossref_primary_10_1016_S1470_2045_19_30673_4 crossref_primary_10_1111_ajd_13234 crossref_primary_10_1167_iovs_65_10_4 crossref_primary_10_1155_2020_7354275 crossref_primary_10_1080_01676830_2024_2382268 crossref_primary_10_3390_ijms23094877 crossref_primary_10_1007_s00508_024_02349_x crossref_primary_10_1136_bjo_2025_327790 crossref_primary_10_1016_j_jaad_2023_07_1013 crossref_primary_10_1167_iovs_64_15_16 crossref_primary_10_4103_IJO_IJO_167_24 crossref_primary_10_1016_j_jcjo_2020_07_017 crossref_primary_10_1186_s12886_020_01367_3 crossref_primary_10_1038_s41433_022_02025_2 crossref_primary_10_1159_000538537 crossref_primary_10_1016_j_jcjo_2024_09_003 crossref_primary_10_1097_IOP_0000000000001863 crossref_primary_10_1097_IOP_0000000000002039 crossref_primary_10_5106_jjshns_35_67 crossref_primary_10_1016_j_jdin_2024_03_012 crossref_primary_10_1007_s10384_025_01187_2 crossref_primary_10_1097_IOP_0000000000001472 crossref_primary_10_1016_j_ophtha_2021_01_012 crossref_primary_10_1097_DSS_0000000000002660 crossref_primary_10_1016_j_clindermatol_2024_01_004 crossref_primary_10_1111_ddg_15405 crossref_primary_10_7759_cureus_56838
Cites_doi	10.1136/bjophthalmol-2017-311533 10.1007/s10384-014-0321-9 10.1097/IOP.0000000000000901 10.1007/s10792-016-0187-6 10.1016/j.ophtha.2004.07.031 10.1043/1543-2165-133.8.1256 10.1016/j.ajo.2016.08.028 10.1016/S0161-6420(02)01239-3 10.1038/eye.2015.79 10.1016/j.tranon.2015.03.001 10.1016/j.ophtha.2011.11.006 10.1097/IOP.0b013e31827472c5 10.1136/bjophthalmol-2013-303758 10.1016/S0161-6420(01)00719-9 10.5858/133.8.1256
ContentType	Journal Article
Copyright	Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. 2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Copyright_xml	– notice: Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8
DOI	10.1136/bjophthalmol-2018-312635
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest One Academic Middle East (New) MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1468-2079
EndPage	984
ExternalDocumentID	30131380 10_1136_bjophthalmol_2018_312635 bjophthalmol
Genre	Journal Article
GeographicLocations	United States United States--US
GeographicLocations_xml	– name: United States – name: United States--US
GroupedDBID	--- -~X .55 .GJ .VT 0R~ 18M 23N 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN ABAAH ABJNI ABKDF ABMQD ABTFR ABUWG ABVAJ ACCCW ACGFO ACGFS ACGTL ACHTP ACMFJ ACNCT ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FYUFA H13 HAJ HMCUK HYE HZ~ IAO IEA IHR IOF ITC J5H KQ8 L7B M1P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 W8F WH7 WOQ X7M XOL YFH YQY ZGI AAFWJ AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO
ID	FETCH-LOGICAL-b503t-f8b2903abc2616be42b5130b7777266fa9f0a8693fda8574a5ca3d0dc2178eaf3
IEDL.DBID	7X7
ISICitedReferencesCount	67
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000473042100021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0007-1161 1468-2079
IngestDate	Thu Sep 04 20:30:45 EDT 2025 Tue Oct 07 07:22:53 EDT 2025 Thu Apr 03 07:03:08 EDT 2025 Sat Nov 29 03:06:02 EST 2025 Tue Nov 18 21:29:42 EST 2025 Fri Apr 25 03:30:36 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	7
Keywords	eyelid carcinoma metastasis 8th TNM AJCC survival staging system sebaceous carcinoma
Language	English
License	Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-b503t-f8b2903abc2616be42b5130b7777266fa9f0a8693fda8574a5ca3d0dc2178eaf3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://bjo.bmj.com/content/bjophthalmol/103/7/980.full.pdf
PMID	30131380
PQID	2244559324
PQPubID	2041039
PageCount	5
ParticipantIDs	proquest_miscellaneous_2091816818 proquest_journals_2244559324 pubmed_primary_30131380 crossref_primary_10_1136_bjophthalmol_2018_312635 crossref_citationtrail_10_1136_bjophthalmol_2018_312635 bmj_primary_10_1136_bjophthalmol_2018_312635
PublicationCentury	2000
PublicationDate	2019-07-01
PublicationDateYYYYMMDD	2019-07-01
PublicationDate_xml	– month: 07 year: 2019 text: 2019-07-01 day: 01
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	British journal of ophthalmology
PublicationTitleAlternate	Br J Ophthalmol
PublicationYear	2019
Publisher	BMJ Publishing Group LTD
Publisher_xml	– name: BMJ Publishing Group LTD
References	Kaliki, Gupta, Ali 2016; 36 Ford, Thakar, Thuro 2017; 33 Lam, Li, Yuen 2018 Watanabe, Sun, Pirbhai 2013; 97 Takahashi, Takahashi, Nakakura 2016; 171 Cho, Hyun, Choi 2015; 8 Pfeiffer, Savar, Esmaeli 2013; 29 Esmaeli, Nasser, Cruz 2012; 119 Ainbinder, Esmaeli, Groo 2009; 133 Shields, Naseripour, Shields 2002; 109 Shields, Demirci, Marr 2004; 111 Choi, Jin, Lee 2014; 58 Kaliki, Ayyar, Dave 2015; 29 Chao, Shields, Krema 2001; 108 2020050713041982000_103.7.980.11 2020050713041982000_103.7.980.13 Ainbinder (2020050713041982000_103.7.980.2) 2009; 133 Choi (2020050713041982000_103.7.980.4) 2014; 58 Kaliki (2020050713041982000_103.7.980.12) 2015; 29 2020050713041982000_103.7.980.1 Takahashi (2020050713041982000_103.7.980.10) 2016; 171 2020050713041982000_103.7.980.3 2020050713041982000_103.7.980.15 2020050713041982000_103.7.980.14 2020050713041982000_103.7.980.9 Kaliki (2020050713041982000_103.7.980.5) 2016; 36 Ford (2020050713041982000_103.7.980.6) 2017; 33 2020050713041982000_103.7.980.7 2020050713041982000_103.7.980.8
References_xml	– year: 2018 article-title: 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2017-311533 – volume: 58 start-page: 327 year: 2014 article-title: Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-014-0321-9 – volume: 33 start-page: 317 year: 2017 article-title: Prognostic value of the staging system for eyelid tumors in the 7th edition of the American Joint Committee on Cancer Staging Manual publication-title: Ophthalmic Plast Reconstr Surg doi: 10.1097/IOP.0000000000000901 – volume: 36 start-page: 681 year: 2016 article-title: Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification publication-title: Int Ophthalmol doi: 10.1007/s10792-016-0187-6 – volume: 111 start-page: 2151 year: 2004 article-title: Sebaceous carcinoma of the eyelids: personal experience with 60 cases publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.07.031 – volume: 133 start-page: 1256 year: 2009 article-title: Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual publication-title: Arch Pathol Lab Med doi: 10.1043/1543-2165-133.8.1256 – volume: 171 start-page: 67 year: 2016 article-title: Risk factors for local recurrence or metastasis of eyelid sebaceous gland carcinoma after wide excision with paraffin section control publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2016.08.028 – volume: 109 start-page: 2129 year: 2002 article-title: Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01239-3 – volume: 29 start-page: 958 year: 2015 article-title: Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians publication-title: Eye doi: 10.1038/eye.2015.79 – volume: 8 start-page: 119 year: 2015 article-title: Significance of lymph node metastasis in cancer dissemination of head and neck cancer publication-title: Transl Oncol doi: 10.1016/j.tranon.2015.03.001 – volume: 119 start-page: 1078 year: 2012 article-title: American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.11.006 – volume: 29 start-page: 57 year: 2013 article-title: Sentinel lymph node biopsy for eyelid and conjunctival tumors: what have we learned in the past decade? publication-title: Ophthalmic Plast Reconstr Surg doi: 10.1097/IOP.0b013e31827472c5 – volume: 97 start-page: 1459 year: 2013 article-title: Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-303758 – volume: 108 start-page: 1877 year: 2001 article-title: Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00719-9 – ident: 2020050713041982000_103.7.980.13 doi: 10.1016/S0161-6420(02)01239-3 – volume: 171 start-page: 67 year: 2016 ident: 2020050713041982000_103.7.980.10 article-title: Risk factors for local recurrence or metastasis of eyelid sebaceous gland carcinoma after wide excision with paraffin section control publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2016.08.028 – volume: 29 start-page: 958 year: 2015 ident: 2020050713041982000_103.7.980.12 article-title: Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians publication-title: Eye doi: 10.1038/eye.2015.79 – volume: 36 start-page: 681 year: 2016 ident: 2020050713041982000_103.7.980.5 article-title: Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification publication-title: Int Ophthalmol doi: 10.1007/s10792-016-0187-6 – ident: 2020050713041982000_103.7.980.9 – volume: 33 start-page: 317 year: 2017 ident: 2020050713041982000_103.7.980.6 article-title: Prognostic value of the staging system for eyelid tumors in the 7th edition of the American Joint Committee on Cancer Staging Manual publication-title: Ophthalmic Plast Reconstr Surg doi: 10.1097/IOP.0000000000000901 – ident: 2020050713041982000_103.7.980.15 doi: 10.1097/IOP.0b013e31827472c5 – ident: 2020050713041982000_103.7.980.1 doi: 10.1016/j.ophtha.2004.07.031 – ident: 2020050713041982000_103.7.980.8 doi: 10.1136/bjophthalmol-2013-303758 – ident: 2020050713041982000_103.7.980.14 doi: 10.1016/j.tranon.2015.03.001 – volume: 133 start-page: 1256 year: 2009 ident: 2020050713041982000_103.7.980.2 article-title: Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual publication-title: Arch Pathol Lab Med doi: 10.5858/133.8.1256 – volume: 58 start-page: 327 year: 2014 ident: 2020050713041982000_103.7.980.4 article-title: Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-014-0321-9 – ident: 2020050713041982000_103.7.980.3 doi: 10.1016/j.ophtha.2011.11.006 – ident: 2020050713041982000_103.7.980.11 doi: 10.1016/S0161-6420(01)00719-9 – ident: 2020050713041982000_103.7.980.7 doi: 10.1136/bjophthalmol-2017-311533
SSID	ssj0002617
Score	2.5195804
Snippet	Background/aimsTo validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis... To validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in...
SourceID	proquest pubmed crossref bmj
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	980
SubjectTerms	Adult Aged Aged, 80 and over Biopsy Cancer therapies Chemotherapy Classification Committees Ethnicity Eye cancer Eyelid Neoplasms - diagnosis Eyelid Neoplasms - mortality Eyelid Neoplasms - secondary Eyelids - pathology Family medical history Female Follow-Up Studies Head & neck cancer Humans Incidence Lymphatic Metastasis Lymphatic system Male Medical prognosis Metastasis Middle Aged Neoplasm Recurrence, Local - epidemiology Neoplasm Staging Ophthalmology Patients Plastic surgery Prognosis Retrospective Studies Sebaceous Gland Neoplasms - diagnosis Sebaceous Gland Neoplasms - mortality Sebaceous Gland Neoplasms - secondary Survival Rate - trends Tumors United States - epidemiology
Title	Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients
URI	https://bjo.bmj.com/content/103/7/980.full https://www.ncbi.nlm.nih.gov/pubmed/30131380 https://www.proquest.com/docview/2244559324 https://www.proquest.com/docview/2091816818
Volume	103
WOSCitedRecordID	wos000473042100021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1468-2079 dateEnd: 20250609 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: 7X7 dateStart: 19220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-2079 dateEnd: 20250609 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: BENPR dateStart: 19220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKi7gBLa-lDxmJY6MmcTZxuKCCWnFhtUJF2lvkp7rVbryss5V654cz43gDHKgqkUMuiZPI39jzeTyZj5D3MlWouSiS3EiZFLooEy6x5L4GY7Gl4KJWQWyimkz4bFZPY8DNx7TK7ZwYJmrtFMbIz8DVFMB-wf9_XP1IUDUKd1ejhMYjsoey2Wjn1WxYcIVq4z39rZIMqM02k4eVZ_LGra67a7FYugVYSoZBQqzLAi5GLm_-dlL_YJ7BA10--99vf06eRu5Jz3tj2Sc7pj0gT77G3fUX5Od07TDvDi7TqMNDgdPS4O_oGiPz4d_AU7o0nQBa6eeeilZTv4EJB0w23O2NFMq4jacKdYpatxTUWQpEk5o7s5jrD9TJIRbs6byF7kppLPDqX5LvlxdXn78kUaUhkeOUdYnlMq9TJqSC7i6lKXI5BscoKzjA-1tR21TwsmZWCz6uCjFWgulUK1gMcSMse0V2W9eaN4RWTGbWIKkyHJaNuQDMFEu1zcF-WF2OyCmA06z6OhxNWL-wsvkTywaxbHosR6TaotioWPEchTcWD2iZDS0f_rajLfhNnAd88xv5EXk3XIYRjNsyokUw4Bl1huonGR-R172BDS9lWA6J8fTt_Q8_xHAD5rFgGvER2e3WG3NMHqvbbu7XJ2FQhDM_IXufLibTb78A9lsYGA
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgqCX8ip0SwEjwa1RkzibOJUQQkDVqu2qhyLtLfgVdavdZFlnQb3ze_iNnckLOIB66YFcHTtR_HnmG3syH8Br5WvSXJReaJXyIhPFnlBUct8gWPJYCpnqWmwiGY3EeJyersDP7l8YSqvsbGJtqE2paY98F11NhOwX_f-7-VePVKPodLWT0GhgcWQvv2PI5t4efsT5fROG-5_OPhx4raqAp4Y-r7xcqDD1uVQag4dY2ShUQzTkKsELvVUu09yXIk55bqQYJpEcasmNbzSSd2FlznHcW3Ab7XhCwV4y7gO8urp5Q7cTL0Aq1WUO8XhXXZTz8-pcTmflFJEZ0KYk1YFBl6ZmF386xb8w3drj7d__377VA1hvuTV73yyGh7Bii0dw96TNHngMP04XJeUVYjNrdYYYcnZW-3O2oJOH-t_HHTazlUTa7CaOycIwt0SDikuyvttZJbUtl45p0mEqyplkZc6QSDN7aacTs8dK1e91OzYpcHp81hawdRvw-Ua-wRNYLcrCbgJLuApyS6TRCgyLQ4kY0dw3eYjrg6fxAHYQDNm8qTOS1fEZj7PfsZMRdrIGOwNIOtRkuq3oTsIi02v0DPqe13_adge2rLVzLvuFtAG86pvRQtGxkyxoMnCMNCB1l0AM4GkD6P6hnMo9ceFv_Xvwl3Dv4OzkODs-HB09gzV8q7RJmd6G1WqxtM_hjv5WTdziRb0gGXy5aVRfAasrcrE
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLaq48H4sFDAS3BptEmcTBwkhoF1RFVYrBFJvwXZsdavdZFlnQb3zq_h1zOQFHEC99ECujp3I_jzz2R7PB_BU-Zo0F6UXGqW8KI9iTyhKuZ8jWGwshUx1LTaRTKfi-DidbcGP7i4MhVV2NrE21HmpaY98hK4mQvaL_n9k27CI2f7k5eqLRwpSdNLayWk0EDkyZ99w-eZeHO7jWD8Lw8nBxzdvvVZhwFNjn1eeFSpMfS6VxoVErEwUqjEadZXgg57LytT6UsQpt7kU4ySSYy157ucaibww0nJs9xJsJ0gyogFsvz6Yzj70foBynTfkO_ECJFZdHBGPR-q0XJ1UJ3KxLBeI04C2KCkrDDo4tTz900X-hffW_m9y7X_uuetwtWXd7FUzTW7Aliluws77Nq7gFnyfrUuKOMRi1ioQMWTzrPb0bE1nEvWtyD22NJVEQu3mjskiZ26DphYna_22M0pqU24c06TQVJRLyUrLkGIzc2YW8_w5K1W_C-7YvMCh8lmb2tbdhk8X0gd3YFCUhbkHLOEqsIbopBG4YA4l4kVzP7chzhyexkPYQ2BkqyYDSVav3Hic_Y6jjHCUNTgaQtIhKNNtrneSHFmco2bQ1zz_13Y74GWtBXTZL9QN4UlfjLaLDqRkQYOBbaQB6b4EYgh3G3D3H-WUCIoL__6_G38MOwjm7N3h9OgBXMGfSptY6l0YVOuNeQiX9ddq7taP2tnJ4PNFw_onOKV80Q
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+factors+for+local+recurrence%2C+metastasis+and+survival+for+sebaceous+carcinoma+of+the+eyelid%3A+observations+in+100+patients&rft.jtitle=British+journal+of+ophthalmology&rft.au=Ho-Seok+Sa&rft.au=Rubin%2C+Maria+Laura&rft.au=Xu%2C+Shiqiong&rft.au=Ning%2C+Jing&rft.date=2019-07-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=0007-1161&rft.eissn=1468-2079&rft.volume=103&rft.issue=7&rft.spage=980&rft_id=info:doi/10.1136%2Fbjophthalmol-2018-312635&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1161&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1161&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1161&client=summon